Authors:
Dronda, F
Casado, JL
Moreno, S
Hertogs, K
Garcia-Arata, I
Antela, A
Perez-Elias, MJ
Ruiz, L
Larder, B
Citation: F. Dronda et al., Phenotypic cross-resistance to nelfinavir: The role of prior antiretroviral therapy and the number of mutations in the protease gene, AIDS RES H, 17(3), 2001, pp. 211-215
Authors:
Casado, JL
Dronda, F
Hertogs, K
Sabido, R
Antela, A
Marti-Belda, P
Dehertogh, P
Moreno, S
Citation: Jl. Casado et al., Efficacy, tolerance, and pharmacokinetics of the combination of stavudine,nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure, AIDS RES H, 17(2), 2001, pp. 93-98
Citation: Jif. Martin et al., Erythema elevatum diutinum, a clinical entity to be considered in patientsinfected with HIV-1, CLIN EXP D, 26(8), 2001, pp. 725-726
Authors:
Moreno, A
Perez-Elias, MJ
Casado, JL
Munoz, V
Antela, A
Dronda, F
Navas, E
Moreno, S
Citation: A. Moreno et al., Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes, AIDS, 15(8), 2001, pp. 1068-1070
Authors:
Podzamczer, D
Mallolas, J
Pena, JM
Pulido, F
Aguirrebengoa, K
Barros, C
Blazquez, R
Costa, JR
Dronda, F
Ena, J
Guerrero, A
Gutierrez, F
Juega, J
Labarga, P
Locutura, J
Aldeguer, JL
Moreno, S
Noguerado, A
Ocana, I
Padilla, B
Perez-Cecilia, E
Elias, MJP
Portilla, J
Rivero, A
Roca, V
Citation: D. Podzamczer et al., Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy, ENFERM INF, 19(8), 2001, pp. 376-392
Citation: F. Dronda et al., 27-year old male patient with AIDS and fever, lymph node enlargement and recent onset immature in peripheral blood, REV CLIN ES, 201(6), 2001, pp. 352-361
Authors:
Moreno, A
Perez-Elias, MJ
Casado, JL
Munoz, V
Antela, A
Dronda, F
Navas, E
Fortun, J
Quereda, C
Moreno, S
Citation: A. Moreno et al., Effectiveness and pitfalls of initial highly active antiretroviral therapyin HIV-infected patients in routine clinical practice, ANTIVIR TH, 5(4), 2000, pp. 243-248
Authors:
Perez-Elias, MJ
Lanier, R
Munoz, V
Garcia-Arata, I
Casado, JL
Marti-Belda, P
Moreno, A
Dronda, F
Antela, A
Marco, S
Moreno, S
Citation: Mj. Perez-elias et al., Phenotypic testing predicts virological response in successive protease inhibitor-based regimens, AIDS, 14(9), 2000, pp. F95-F101
Authors:
Casado, JL
Dronda, F
Hertogs, K
Antela, A
Moreno, S
Citation: Jl. Casado et al., Failure of a ritonavir plus saquinavir-based rescue regimen precludes the use of protease inhibitors, AIDS, 14(4), 2000, pp. 466-468
Authors:
Casado, JL
Hertogs, K
Ruiz, L
Dronda, F
Van Cauwenberge, A
Arno, A
Garcia-Arata, I
Bloor, S
Bonjoch, A
Blazquez, J
Clotet, B
Larder, B
Citation: Jl. Casado et al., Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen, AIDS, 14(2), 2000, pp. F1-F7
Authors:
Dronda, F
Navas, E
Pintado, V
Gomez-Mampaso, E
Citation: F. Dronda et al., Pulmonary infection caused by Mycobacterium xenopi following initiation ofhighly effective treatment with Indinavir, REV CLIN ES, 200(6), 2000, pp. 347-348
Authors:
Casado, JL
Sabido, R
Perez-Elias, MJ
Antela, A
Oliva, J
Dronda, F
Mejia, B
Fortun, J
Citation: Jl. Casado et al., Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients, ANTIVIR TH, 4(3), 1999, pp. 157-161
Authors:
Dronda, F
Perez-Elias, MJ
Antela, A
Casado, JL
Marti-Belda, P
Cobo, J
Citation: F. Dronda et al., Patients failing saquinavir therapy require an early change to indinavir before HIV-1 viral load reaches high levels, ANTIVIR TH, 4(2), 1999, pp. 117-121
Authors:
Chaves, F
Dronda, F
Alonso-Sanz, M
Noriega, AR
Citation: F. Chaves et al., Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates, AIDS, 13(5), 1999, pp. 615-620